GO
| HSI1 | 25,774.14 | 0.00 | -- |
| HSCEI1 | 8,913.83 | 0.00 | -- |
| Back Zoom + Zoom - Block Traded | |
|
SIMCERE PHARMA: SIM0610 Approved for Clinical Trials in CN
2025-12-23 17:19:42 SIMCERE PHARMA (02096.HK) announced that the Group’s independently developed Bispecific Antibody-Drug Conjugate (BsADC) investigational new drug candidate, SIM0610, had received the Clinical Trial Approval issued by the National Medical Products Administration of China, and is intended to be evaluated in patients with locally advanced or metastatic solid tumors. ~ AASTOCKS Financial News Website: www.aastocks.com | |